-
1
-
-
85017805884
-
-
Lake Forest, IL: Hospira, Inc;:1-8.
-
1 Vancomycin full prescribing information. Lake Forest, IL: Hospira, Inc; 2011:1-8.
-
(2011)
-
-
-
2
-
-
84856176691
-
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database
-
2 Cano, E.L., Haque, N.Z., Welch, V.L., et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 34 (2012), 149–157.
-
(2012)
Clin Ther
, vol.34
, pp. 149-157
-
-
Cano, E.L.1
Haque, N.Z.2
Welch, V.L.3
-
3
-
-
84864609103
-
Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort
-
3 Kullar, R., Davis, S.L., Taylor, T.N., Kaye, K.S., Rybak, M.J., Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort. Pharmacotherapy 32 (2012), 195–201.
-
(2012)
Pharmacotherapy
, vol.32
, pp. 195-201
-
-
Kullar, R.1
Davis, S.L.2
Taylor, T.N.3
Kaye, K.S.4
Rybak, M.J.5
-
4
-
-
1042276996
-
Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
-
4 Charles, P.G.P., Ward, P.B., Johnson, P.D.R., Howden, B.P., Grayson, M.L., Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 38 (2004), 448–451.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 448-451
-
-
Charles, P.G.P.1
Ward, P.B.2
Johnson, P.D.R.3
Howden, B.P.4
Grayson, M.L.5
-
5
-
-
59749104464
-
Vancomycin ototoxicity: a reevaluation in an era of increasing doses
-
5 Forouzesh, A., Moise, P.A., Sakoulas, G., Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother 53 (2009), 483–486.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 483-486
-
-
Forouzesh, A.1
Moise, P.A.2
Sakoulas, G.3
-
6
-
-
84903643749
-
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
-
6 Frazee, E.N., Rule, A.D., Herrmann, S.M., et al. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care, 18, 2014, R110.
-
(2014)
Crit Care
, vol.18
, pp. R110
-
-
Frazee, E.N.1
Rule, A.D.2
Herrmann, S.M.3
-
7
-
-
33744527833
-
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
-
7 Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
-
(2006)
Crit Care Med
, vol.34
, pp. 1589-1596
-
-
Kumar, A.1
Roberts, D.2
Wood, K.E.3
-
8
-
-
84873339299
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
-
8 Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2013), 580–637.
-
(2013)
Crit Care Med
, vol.41
, pp. 580-637
-
-
Dellinger, R.P.1
Levy, M.M.2
Rhodes, A.3
-
9
-
-
84930421453
-
Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery
-
9 Petrovic, S., Bogavac-Stanojevic, N., Lakic, D., et al. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Biochem Med (Zagreb) 25 (2015), 262–271.
-
(2015)
Biochem Med (Zagreb)
, vol.25
, pp. 262-271
-
-
Petrovic, S.1
Bogavac-Stanojevic, N.2
Lakic, D.3
-
10
-
-
41849098447
-
Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children
-
10 Narvaez-Sanchez, R., Gonzalez, L., Salamanca, A., et al. Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children. Clin Biochem 41 (2008), 498–503.
-
(2008)
Clin Biochem
, vol.41
, pp. 498-503
-
-
Narvaez-Sanchez, R.1
Gonzalez, L.2
Salamanca, A.3
-
11
-
-
0030690056
-
The threat to medical-records research
-
11 Melton, L.J. 3rd, The threat to medical-records research. N Engl J Med 337 (1997), 1466–1470.
-
(1997)
N Engl J Med
, vol.337
, pp. 1466-1470
-
-
Melton, L.J.1
-
12
-
-
79959777460
-
Mayo Clinic Antimicrobial Therapy: Quick Guide
-
2nd ed. Oxford University Press Inc New York, NY
-
12 Wilson, J., Estes, L., Mayo Clinic Antimicrobial Therapy: Quick Guide. 2nd ed., 2012, Oxford University Press Inc, New York, NY.
-
(2012)
-
-
Wilson, J.1
Estes, L.2
-
13
-
-
67651083250
-
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
-
13 Rybak, M.J., Lomaestro, B.M., Rotschafer, J.C., et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49 (2009), 325–327.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 325-327
-
-
Rybak, M.J.1
Lomaestro, B.M.2
Rotschafer, J.C.3
-
14
-
-
84864603916
-
Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation
-
14 Winter, M.A., Guhr, K.N., Berg, G.M., Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy 32 (2012), 604–612.
-
(2012)
Pharmacotherapy
, vol.32
, pp. 604-612
-
-
Winter, M.A.1
Guhr, K.N.2
Berg, G.M.3
-
15
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
15 Cockcroft, D.W., Gault, M.H., Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976), 31–41.
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
16
-
-
79951821210
-
Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary
-
16 Liu, C., Bayer, A., Cosgrove, S.E., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52 (2011), 285–292.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 285-292
-
-
Liu, C.1
Bayer, A.2
Cosgrove, S.E.3
-
17
-
-
0003858901
-
The Six Sigma Handbook: A Complete Guide for Green Belts, Black Belts, and Managers at All Levels
-
3rd ed. McGraw Hill New York, NY
-
17 Pyzdek, T., Keller, P.A., The Six Sigma Handbook: A Complete Guide for Green Belts, Black Belts, and Managers at All Levels. 3rd ed., 2010, McGraw Hill, New York, NY.
-
(2010)
-
-
Pyzdek, T.1
Keller, P.A.2
-
18
-
-
33744839368
-
Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known
-
18 Du Bois, D., Du Bois, E., Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17 (1916), 863–871.
-
(1916)
Arch Intern Med
, vol.17
, pp. 863-871
-
-
Du Bois, D.1
Du Bois, E.2
-
19
-
-
84863524855
-
Estimating glomerular filtration rate from serum creatinine and cystatin C [erratum in N Engl J Med. 2012;367(7):681]
-
19 Inker, L.A., Schmid, C.H., Tighiouart, H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C [erratum in N Engl J Med. 2012;367(7):681]. N Engl J Med 367 (2012), 20–29.
-
(2012)
N Engl J Med
, vol.367
, pp. 20-29
-
-
Inker, L.A.1
Schmid, C.H.2
Tighiouart, H.3
-
20
-
-
33846153776
-
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
-
20 Dellit, T.H., Owens, R.C., McGowan, J.E. Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44 (2007), 159–177.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 159-177
-
-
Dellit, T.H.1
Owens, R.C.2
McGowan, J.E.3
-
21
-
-
84884342549
-
KDIGO clinical practice guideline for acute kidney injury
-
21 Kellum, J.A., Lameire, N., KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
-
(2012)
Kidney Int Suppl
, vol.2
, pp. 1-138
-
-
Kellum, J.A.1
Lameire, N.2
-
22
-
-
84856937734
-
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study
-
22 Wunderink, R.G., Niederman, M.S., Kollef, M.H., et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54 (2012), 621–629.
-
(2012)
Clin Infect Dis
, vol.54
, pp. 621-629
-
-
Wunderink, R.G.1
Niederman, M.S.2
Kollef, M.H.3
-
23
-
-
62049084378
-
Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support
-
23 Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
-
(2009)
J Biomed Inform
, vol.42
, pp. 377-381
-
-
Harris, P.A.1
Taylor, R.2
Thielke, R.3
Payne, J.4
Gonzalez, N.5
Conde, J.G.6
-
24
-
-
84875215709
-
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
-
24 Kanda, Y., Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48 (2013), 452–458.
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 452-458
-
-
Kanda, Y.1
-
25
-
-
84862965924
-
Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization
-
25 Brown, J., Brown, K., Forrest, A., Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother 56 (2012), 634–638.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 634-638
-
-
Brown, J.1
Brown, K.2
Forrest, A.3
-
26
-
-
7444254040
-
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
-
26 Moise-Broder, P.A., Forrest, A., Birmingham, M.C., Schentag, J.J., Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43 (2004), 925–942.
-
(2004)
Clin Pharmacokinet
, vol.43
, pp. 925-942
-
-
Moise-Broder, P.A.1
Forrest, A.2
Birmingham, M.C.3
Schentag, J.J.4
-
27
-
-
84958115367
-
Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients
-
27 Kees, M.G., Minichmayr, I.K., Moritz, S., et al. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients. J Clin Pharmacol 56:3 (2016), 307–315.
-
(2016)
J Clin Pharmacol
, vol.56
, Issue.3
, pp. 307-315
-
-
Kees, M.G.1
Minichmayr, I.K.2
Moritz, S.3
-
28
-
-
84930169502
-
Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury–does the use of cystatin C improve accuracy?
-
28 DeCarolis, D.D., Thorson, J.G., Marraffa, R.A., Clairmont, M.A., Kuskowski, M.A., Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury–does the use of cystatin C improve accuracy?. Ther Drug Monit 36 (2014), 632–639.
-
(2014)
Ther Drug Monit
, vol.36
, pp. 632-639
-
-
DeCarolis, D.D.1
Thorson, J.G.2
Marraffa, R.A.3
Clairmont, M.A.4
Kuskowski, M.A.5
-
29
-
-
84874774161
-
Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations
-
29 Chung, J.Y., Jin, S.J., Yoon, J.H., Song, Y.G., Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations. J Korean Med Sci 28 (2013), 48–54.
-
(2013)
J Korean Med Sci
, vol.28
, pp. 48-54
-
-
Chung, J.Y.1
Jin, S.J.2
Yoon, J.H.3
Song, Y.G.4
-
30
-
-
33748206739
-
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin
-
30 Hermida, J., Tutor, J.C., Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. Ther Drug Monit 28 (2006), 326–331.
-
(2006)
Ther Drug Monit
, vol.28
, pp. 326-331
-
-
Hermida, J.1
Tutor, J.C.2
-
31
-
-
78249275544
-
Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C
-
31 Kees, M.G., Hilpert, J.W., Gnewuch, C., Kees, F., Voegeler, S., Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 36 (2010), 545–548.
-
(2010)
Int J Antimicrob Agents
, vol.36
, pp. 545-548
-
-
Kees, M.G.1
Hilpert, J.W.2
Gnewuch, C.3
Kees, F.4
Voegeler, S.5
-
32
-
-
33947634111
-
Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients
-
32 Okamoto, G., Sakamoto, T., Kimura, M., et al. Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients. Clin Biochem 40 (2007), 485–490.
-
(2007)
Clin Biochem
, vol.40
, pp. 485-490
-
-
Okamoto, G.1
Sakamoto, T.2
Kimura, M.3
-
33
-
-
75749128980
-
Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function
-
33 Tanaka, A., Aiba, T., Otsuka, T., et al. Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. Antimicrob Agents Chemother 54 (2010), 778–782.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 778-782
-
-
Tanaka, A.1
Aiba, T.2
Otsuka, T.3
-
34
-
-
34248225362
-
Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function
-
34 Tanaka, A., Suemaru, K., Otsuka, T., et al. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit 29 (2007), 261–264.
-
(2007)
Ther Drug Monit
, vol.29
, pp. 261-264
-
-
Tanaka, A.1
Suemaru, K.2
Otsuka, T.3
-
35
-
-
35748969133
-
Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin
-
35 Tanaka, A., Suemaru, K., Otsuka, T., et al. Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin. Int J Clin Pharmacol Ther 45 (2007), 592–597.
-
(2007)
Int J Clin Pharmacol Ther
, vol.45
, pp. 592-597
-
-
Tanaka, A.1
Suemaru, K.2
Otsuka, T.3
-
36
-
-
84933046086
-
Cystatin C as a potential biomarker for dosing of renally excreted drugs
-
36 Brou, N.A., Jacqz-Aigrain, E., Zhao, W., Cystatin C as a potential biomarker for dosing of renally excreted drugs. Br J Clin Pharmacol 80 (2015), 20–27.
-
(2015)
Br J Clin Pharmacol
, vol.80
, pp. 20-27
-
-
Brou, N.A.1
Jacqz-Aigrain, E.2
Zhao, W.3
-
37
-
-
79955620196
-
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines
-
37 Kullar, R., Leonard, S.N., Davis, S.L., et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy 31 (2011), 441–448.
-
(2011)
Pharmacotherapy
, vol.31
, pp. 441-448
-
-
Kullar, R.1
Leonard, S.N.2
Davis, S.L.3
-
38
-
-
62849095029
-
Pharmacokinetic issues for antibiotics in the critically ill patient
-
quiz 859
-
38 Roberts, J.A., Lipman, J., Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37 (2009), 840–851 quiz 859.
-
(2009)
Crit Care Med
, vol.37
, pp. 840-851
-
-
Roberts, J.A.1
Lipman, J.2
-
39
-
-
29244442296
-
The pharmacokinetic and pharmacodynamic properties of vancomycin
-
39 Rybak, M.J., The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42:suppl 1 (2006), S35–S39.
-
(2006)
Clin Infect Dis
, vol.42
, pp. S35-S39
-
-
Rybak, M.J.1
-
40
-
-
66149108761
-
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
-
40 Pea, F., Furlanut, M., Negri, C., et al. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 53 (2009), 1863–1867.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1863-1867
-
-
Pea, F.1
Furlanut, M.2
Negri, C.3
|